Literature DB >> 19765473

Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.

M Ounissi1, E Abderrahim, S Trabelsi, S Khaled, H Bezzine, F Ben Hamida, H Hedri, T Ben Abdallah, H Ben Maïz, A Kheder.   

Abstract

Hyalohyphomycosis caused by Paecilomyces has rarely been described among solid organ recipients. Its management is elusive without an established consensus concerning antifungal therapy. Herein we have reported a case of extensive cellulitis caused by Paecilomyces lilacinus observed in a 48-year-old kidney transplanted woman with hepatitis C. Kidney transplantation from a cadaveric donor was performed in October 2006 with an uneventful early course except for posttransplant diabetes mellitus and a reversible acute rejection episode. Cutaneous nodular and verrucous lesions of the left leg appeared in August 2007. In a few weeks, these lesions become ulcerated, hemorrhagic, and painful. The diagnosis was made on the basis of microbiologic culture and histological examination. There was no improvement in the skin lesions after 6 weeks treatment with itraconazole, but voriconazole yielded a good response within the first 2 weeks. There was a good tolerance to antifungal therapy; graft function and liver tests remained normal. We concluded that an increasing emerging of fungal infections is observed with the introduction of more powerful immunosuppressive drugs. Diagnosis and management of such infections is elusive. Preventive measures should be considered including the adaptation of immunosuppressive therapy among at-risk patients especially those with hepatitis C virus infection and diabetics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765473     DOI: 10.1016/j.transproceed.2009.07.035

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.

Authors:  Maryam Keshtkar-Jahromi; Arthur H McTighe; Keith A Segalman; Annette W Fothergill; Wayne N Campbell
Journal:  Mycopathologia       Date:  2012-04-08       Impact factor: 2.574

2.  Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.

Authors:  Ziauddin Khan; Suhail Ahmad; Fahad Al-Ghimlas; Sana Al-Mutairi; Leena Joseph; Rachel Chandy; Deanna A Sutton; Josep Guarro
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

Review 3.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

Review 4.  Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.

Authors:  Ramzy H Rimawi; Yvonne Carter; Thomas Ware; John Christie; Dawd Siraj
Journal:  Mycopathologia       Date:  2013-01-20       Impact factor: 2.574

5.  Chronic subcutaneous infection of Purpureocillium lilacinum in an immunocompromised patient: Case report and review of the literature.

Authors:  Robin Albert; Adrien Lemaignen; Guillaume Desoubeaux; Eric Bailly; Louis Bernard; Marion Lacasse
Journal:  Med Mycol Case Rep       Date:  2022-09-03

6.  Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum.

Authors:  Julia Accetta; Emily Powell; Erin Boh; Lisa Bull; Abida Kadi; Alfred Luk
Journal:  Med Mycol Case Rep       Date:  2020-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.